Adlai Nortye Group Ltd.
ANL Nasdaq· Pharmaceutical Preparations
Last close · Oct 23, 2026
$10.58
KIRA · Stoqly’s AI analyst, in plain words
- Adlai Nortye Group Ltd. had $5.0M of revenue in fiscal 2025.
- Its operating margin was −714.0%: of every 100 in sales, about −714 is left after running the business.
- Adlai Nortye Group Ltd. lost $35.5M in fiscal 2025.
- Free cash flow was −$33.6M in fiscal 2025, −672.8% of revenue.
- Adlai Nortye Group Ltd. owes $16.5M more than it holds in cash.
Market cap
$338M
P/E
—
Revenue
$5.0M
Net income
−$35.5M
Free cash flow
−$33.6M
Operating margin
−714.0%
Adlai Nortye Group Ltd. in 30 seconds · fiscal 2025
Does it make a profit?
−710.6%
No. It lost money last year.
Does profit turn into cash?
−672.8%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 7
Weak. It passes 1 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Adlai Nortye Group Ltd. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 10, 2026
- Legal name
- Adlai Nortye Group Ltd.
- CIK
- 0001944552
Adlai Nortye Group Ltd. · ANL
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $45.7M | — | $5.0M | — | $5.0M |
| Operating margin | −18.9% | — | −1,451.0% | — | −714.0% |
| Net income | −$56.7M | −$58.8M | −$109M | −$51.9M | −$35.5M |
| Net margin | −124.0% | — | −2,184.6% | — | −710.6% |
| Diluted EPS | −$6.69 | −$6.93 | −$7.56 | −$1.62 | −$1.11 |
| Cash | |||||
| Cash from operations | −$3.0M | −$43.2M | −$56.7M | −$51.8M | −$33.5M |
| Capital expenditure | $1.0M | $1.2M | $0.2M | $0.2M | $0.2M |
| Free cash flow | −$4.1M | −$44.5M | −$56.9M | −$52.0M | −$33.6M |
| FCF margin | −8.9% | — | −1,137.0% | — | −672.8% |
| Share count change | — | 0.0% | 70.4% | 121.0% | 0.2% |
| Debt and strength | |||||
| Cash and short-term investments | $64.1M | $42.8M | $91.5M | $60.9M | $8.1M |
| Debt incl. finance leases | $10.5M | $4.3M | $30.4M | $26.3M | $24.6M |
| Shareholders' equity | −$185M | −$241M | $75.0M | $25.5M | −$8.3M |
| Current ratio | — | 0.2x | 2.0x | 1.4x | 0.6x |
| Interest coverage | −6.5x | −155.4x | −91.7x | −27.2x | −23.3x |
| Returns and quality | |||||
| Return on capital | — | — | −412.0% | — | −343.8% |
| Return on equity | — | — | — | −103.2% | −414.0% |
| Return on tangible equity | — | — | −145.7% | −203.8% | — |
| Piotroski F-score | — | — | 2 | 2 | 1 |
| Altman Z'' | — | −41.3 | 0.4 | −22.3 | −54.0 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.4M
3 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Adlai Nortye Group Ltd. · ANL
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $10.58 a share, the company is worth $338M.
Source: SEC EDGAR XBRL filings (CIK 0001944552). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.